Trixeo Aerosphere European Union - English - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Amaryl (M) 250 mg, 1 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

amaryl (m) 250 mg, 1 mg

شركة ألفه للأدوية - ulfa pharma co. - metformin hcl 250 mg, glimepiride 1 mg - 250 mg, 1 mg

Symbicort Turbuhaler 160 mcg/dose, Dihydrate 4.5 mcg/dose Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

symbicort turbuhaler 160 mcg/dose, dihydrate 4.5 mcg/dose

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - budesonide 160 mcg/dose, formoterol fumarate dihydrate 4.5 mcg/dose - 160 mcg/dose, dihydrate 4.5 mcg/dose

Symbicort Turbuhaler 160 mcg/dose, Dihydrate 4.5 mcg/dose Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

symbicort turbuhaler 160 mcg/dose, dihydrate 4.5 mcg/dose

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - budesonide 160 mcg/dose, formoterol fumarate dihydrate 4.5 mcg/dose - 160 mcg/dose, dihydrate 4.5 mcg/dose

Riltrava Aerosphere European Union - English - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1).

TRIXEO AEROSPHERE Israel - English - Ministry of Health

trixeo aerosphere

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate; glycopyrronium - suspension for inhalation - formoterol fumarate dihydrate 5 mcg; glycopyrronium 7.2 mcg; budesonide 160 mcg - budesonide - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist